Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1329
| Despition | PDE6 Beta Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1051 | Recombinant Human Amyloid Precursor Protein Protein (6×His Tag) (AC1051) | 50 µg | inquiry |
| ACPP-1392 | Human Dopa Decarboxylase Protein (AC1392) | 5 µg | inquiry |
| ACPP-1220 | ELOVL4 Blocking Peptide (AC1220) | 250 µg | inquiry |
| ACPP-1263 | MAPK7 Blocking Peptide (AC1263) | 250 µg | inquiry |
| ACPP-1380 | Human LECT2 Protein (AC1380) | 2 µg | inquiry |
| ACPP-1177 | Recombinant Human Prostate Specific Antigen Protein (6×His Tag) (AC1177) | 50 µg | inquiry |
| ACPP-1830 | Human SDC1 Protein (AC1830) | 5 µg | inquiry |
| ACPP-1779 | Human HSD17B10 Protein (AC1779) | 5 µg | inquiry |
| ACPP-1033 | Recombinant Human PTN Protein (Fc Tag) (AC1033) | 50 µg | inquiry |
| ACPP-1382 | Human EYA2 Protein (AC1382) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.